For its first fiscal quarter (ending March 31), CME Group Inc (NASDAQ: CME) has reported E.P.S. of $2.35 compared to $2.43 a year ago. For the latest four quarters through March 31, E.P.S. were $8.79 compared to $7.88 a year ago.
Recent Price Action
On 4/24/24, CME Group Inc (NASDAQ: CME) stock declined modestly by -1.9%, closing at $212.59. Moreover, unusually high trading volume at 161% of normal accompanied the decline. The stock has performed in line with the market over the last nine months and has risen 3.0% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, CME is expected to continue to be an important Value Builder.
CME Group has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. CME Group has a poor Appreciation Score of 26 but a slightly positive Power Rating of 63, producing the Low Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment